protein

ADAM10

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about ADAM10: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

459Connections
0Hypotheses
5Analyses
50Outgoing
50Incoming
0Experiments
6Debates

Summary

ADAM10 (A Disintegrin and Metalloproteinase 10) is the primary alpha-secretase in the non-amyloidogenic processing pathway of amyloid precursor protein (APP). Cleavage by ADAM10 occurs within the Abeta domain, preventing the formation of amyloid-beta peptides and generating the neuroprotective sAPPalpha fragment. ADAM10 is a transmembrane protein belonging to the ADAM family, widely expressed in brain tissue with particularly high activity in neurons. Genetic variants in ADAM10 have been associated with susceptibility to late-onset Alzheimer's disease, and rare pathogenic mutations (including nonsense mutations like Tyr167*) have been identified in familial AD cases. Therapeutic strategies targeting ADAM10 include promoting its activity to shift APP processing away from the amyloidogenic pathway, though no ADAM10-based therapies have yet reached clinical use. ADAM10 also processes other substrates including Notch, TNF-alpha, and ErbB4, making its biology complex and context-dependent.

View on Wiki →

No AI portrait yet

🔬 Protein Info
Gene SymbolADAM10
Full NameA Disintegrin And Metalloproteinase Domain 10
AliasesKuzbanian, CD156c
Chromosome15q21.3
FunctionAlpha-secretase, cleaves APP via non-amyloidogenic pathway
Molecular Weight84.1 kDa
Amino Acids748
PathwaysNon-amyloidogenic APP processing, Notch signaling
UniProt IDO14672
NCBI Gene ID102
Ensembl IDENSG00000137845
OMIM602192
GeneCardsADAM10
Human Protein AtlasADAM10
Associated DiseasesAGING, Als, Alzheimer, Cancer, Dementia
InteractionsACAT1, AD, ADAM17, ADAMTS4, AGING, AKT
KG Connections459 knowledge graph edges
DatabasesGeneCardsHPASTRING
🔮 Predicted Structure: ADAM10 — AlphaFold O14672 Click to expand

AI-predicted structure from AlphaFold | Powered by Mol*

Wiki Pages (2)

Knowledge base pages for this entity

Canonical Page

ADAM10 — A Disintegrin And Metalloproteinase Domain 10

gene · 1696 words

ADAM10 Protein

protein · 658 words

Pathway Diagram

graph TD
    ADAM10["ADAM10"] -->|"biomarker for"| Alzheimer_s_Disease["Alzheimer's Disease"]
    style Alzheimer_s_Disease fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#e0e0e0
    ADAM10["ADAM10"] -->|"regulates"| Notch_pathway["Notch pathway"]
    style Notch_pathway fill:#1a2a3a,stroke:#81c784,stroke-width:1px,color:#e0e0e0
    ADAM10["ADAM10"] -->|"activates"| NLGN3["NLGN3"]
    style NLGN3 fill:#1a2a3a,stroke:#4fc3f7,stroke-width:1px,color:#e0e0e0
    ADAM10["ADAM10"] -->|"associated"| Alzheimer["Alzheimer"]
    style Alzheimer fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#e0e0e0
    ADAM10["ADAM10"] -->|"associated"| Ms["Ms"]
    style Ms fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#e0e0e0
    ADAM10["ADAM10"] -->|"therapeutic target"| Inflammation["Inflammation"]
    style Inflammation fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#e0e0e0
    ADAM10["ADAM10"] -->|"therapeutic target"| Als["Als"]
    style Als fill:#1a2a3a,stroke:#ef5350,stroke-width:1px,color:#e0e0e0
    TREM2["TREM2"] -.->|"inhibits"| ADAM10["ADAM10"]
    style TREM2 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#e0e0e0
    GENES["GENES"] -->|"therapeutic target"| ADAM10["ADAM10"]
    style GENES fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#e0e0e0
    CAPN1["CAPN1"] -->|"therapeutic target"| ADAM10["ADAM10"]
    style CAPN1 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#e0e0e0
    TTR["TTR"] -->|"therapeutic target"| ADAM10["ADAM10"]
    style TTR fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#e0e0e0
    LGALS3["LGALS3"] -->|"therapeutic target"| ADAM10["ADAM10"]
    style LGALS3 fill:#1a2a3a,stroke:#ce93d8,stroke-width:1px,color:#e0e0e0
    style ADAM10 fill:#006494,stroke:#4fc3f7,stroke-width:2px,color:#e0e0e0,font-weight:bold

Outgoing (335)

TargetRelationTypeStr
benchmark_ot_ad_answer_key:ADAM10data_indataset_row0.00
ds-83b31ef18d49provides_data_fordataset1.00
Alzheimer's Diseasebiomarker_fordisease0.95
Notch pathwayregulatespathway0.90
DAM microgliaexpressed_incell_type0.75

Incoming (124)

SourceRelationTypeStr
benchmark_ot_ad_answer_key:ADAM10data_indataset_row0.00
entities-app-proteininteracts_withwiki0.00
ds-83b31ef18d49data_indataset1.00
genes-adam10describeswiki_page0.95
h-trem2-fe8c644atargets_genehypothesis0.90

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (5)

Scientific analyses that reference this entity

Tau propagation mechanisms and therapeutic interception points

neurodegeneration | 2026-04-04 | 15 hypotheses Top: 0.814

Gene expression changes in aging mouse brain predicting neurodegenerative vulner

neurodegeneration | 2026-04-03 | 45 hypotheses Top: 0.990

SEA-AD Gene Expression Profiling — Allen Brain Cell Atlas

neurodegeneration | 2026-04-02 | 5 hypotheses Top: 0.761

TREM2 agonism vs antagonism in DAM microglia

neurodegeneration | 2026-04-02 | 7 hypotheses Top: 0.741

Lipid raft composition changes in synaptic neurodegeneration

neurodegeneration | 2026-04-01 | 12 hypotheses Top: 0.921

Experiments (0)

Experimental studies targeting or related to this entity

ExperimentTypeDiseaseScoreFeasibilityModelStatusEst. Cost
No experiments found

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found

Debates (6)

Multi-agent debates referencing this entity

Investigate prion-like spreading of tau pathology through connected brain region

closed · Rounds: 4 · Score: 0.90 · 2026-04-12

Investigate how lipid raft composition (cholesterol metabolism, sphingolipids) c

closed · Rounds: 5 · Score: 0.93 · 2026-04-11

Tau propagation mechanisms and therapeutic interception points

closed · Rounds: 3 · Score: 0.95 · 2026-04-04

What gene expression changes in the aging mouse brain predict neurodegenerative

closed · Rounds: 4 · Score: 0.95 · 2026-04-03

Cell-type specific expression patterns of neurodegeneration genes in SEA-AD

closed · Rounds: 3 · Score: 0.68 · 2026-04-02

The disease-associated microglia (DAM) phenotype involves TREM2 upregulation, bu

closed · Rounds: 4 · Score: 0.89 · 2026-04-02